NASDAQ:ZBIO | Free Cash Flow | Zenas BioPharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$75.2M$2,000.00-$75.2M
2025-12-31-$52.41M$0.00-$52.41M
2025-03-31-$37.05M$18,000.00-$37.07M
2024-12-31-$38.55M$74,000.00-$38.63M
2024-03-31-$19.1M$22,000.00-$19.12M
2023-12-31-$15.4M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$172.33M$18,000.00-$172.35M
2024-12-31-$119.67M$131,000.00-$119.81M
2023-12-31-$30.53M$17,000.00-$30.55M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.